Fig. 3

Summary of main results. Aspirin reduces the risk of venous thromboembolism (VTE) by 20%, deep vein thrombosis (DVT) by 18%, pulmonary embolism (PE) by 21%, and VTE-related mortality by 56% compared with placebo. Illustration elements adapted from Depositphotos™ (licensed image provider), used under extended license permitting academic publication.